The University of Edinburgh
Clinical, biochemical, haematological and molecular epidemiology of erythropoietic protoporphyria: a United Kingdom cross-sectional study
Abstract
dc:description.abstractThis thesis concerns erythropoietic protoporphyria (EPP, MIM 177000), a rare photodermatosis with systemic complications which results from an inherited partial deficiency of ferrochelatase (FECH), the terminal enzyme of haem biosynthesis. Excessive formation of the substrate, protoporphyrin IX, results in protoporphyrinaemia and accumulation in erythrocytes, plasma, skin and liver, prior to excretion in the bile. Protoporphyrin can absorb light, damaging surrounding tissues through the generation of free radicals, and clinically manifesting as painful photosensitivity within minutes of skin exposure to sunlight. Microcytic anaemia occurs in 20 - 60% of patients. Liver dysfunction and liver failure occurs in up to 35% and 4% of patients respectively. Management of EPP is based mainly on minimising the effects of sunlight by use of visible light sunscreens, clothing and behavioural measures to avoid direct sunlight. Despite advances in the biochemistry and genetic inheritance, there remains a lack of prospective clinical data for EPP. Previous studies have been retrospective analyses, often from tertiary centres specialising in the treatment of liver disease. Such studies typically report subjects in common, many from large family pedigrees. These limitations of ascertainment, bias and small population size have restricted accurate investigation of fundamental clinical issues relating to EPP.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2011
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Holme, Stephen Alexander
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/34668